NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
Retinal Prostheses in the Medicare Population
Technology Assessments, No. 103
Joann Fontanarosa, PhD, Jonathan R Treadwell, PhD, David J Samson, MS, Brian L VanderBeek, MD, MPH, MSCE, and Karen Schoelles, MD, SM.
Author Information and AffiliationsStructured Abstract
Objectives:
To determine the safety, efficacy, and evidence for halting disease progression for retinal prosthesis systems (RPSs) and the outcomes that are and could be assessed in future studies of these devices.
Data sources:
We searched Medline, EMBASE, Cumulative Index to Nursing and Allied Health (CINAHL), the Cochrane Library, PubMed (unprocessed records only), and gray literature sources, including conference proceedings from specialty societies, for studies of RPS devices published from January 1, 2000, through April 25, 2016.
Review methods:
We performed redundant title and abstract screening with one reviewer's selection required for full-text article retrieval. Dual independent review was performed on all full-text articles, with disagreements resolved by consensus. Data extraction was performed by a single reviewer and was fully verified by a second reviewer. Extracted data included study design, psychometric properties assessment methods based on the COSMIN checklist, patient blinding to experimental condition, outcome assessor blinding to experimental condition, experimental condition randomly presented, number of outcome assessors, country/site, number of patients enrolled, patient inclusion criteria, patient exclusion criteria, RPS treatment details, prior treatment, concurrent treatment, study duration, diagnosis, age at diagnosis, age at implantation, eye implanted, time from implantation to study participation, sex, race, visual acuity at time of implantation, outcomes, and outcome definitions. We assessed risk of bias of individual studies for the outcomes of interest, and graded the overall strength of evidence using Evidence-based Practice Centers guidance.
Results:
Eleven studies of RPS effectiveness were included. Although some patients clearly improve on tests of visual function, visual acuity, visual field, color vision, laboratory-based function, and day-to-day function from an RPS, the evidence was insufficient to estimate the proportion of patients who would benefit. Intraoperative adverse events were typically mild but some serious adverse events were reported, including intraocular pressure increase, hypotony, and presumed endophthalmitis. Three studies pointed to the possibility that RPSs may provide neuroprotection. Of the 74 outcomes reported in the 11 included studies, only 4 (Early Treatment of Diabetic Retinopathy Study visual acuity test [ETDRS], Grating Acuity Test [GAT], Chow Color Test [CCT], and Functional Low-Vision Observer Rated Assessment [FLORA]) had evidence of validity and/or reliability. Measures with evidence of validity and reliability that could be used in future RPS studies include full-field flash test, Grating Contrast Sensitivity (GCS), FAST instrument (Functional Assessment of Self-Reliance on Tasks), Very Low Vision Instrumental Activities of Daily Living (IADL-VLV), Modified National Eye Institute Visual Function Questionnaire 25-item (NEI-VFQ-25) plus supplement, and the Modified Impact of Vision Impairment (IVI).
Conclusions:
Some patients clearly benefit from RPSs. Future studies of retinal prosthesis should make an effort to report valid and reliable measures of day-to-day function and quality of life.
Contents
- Preface
- Acknowledgments
- Key Informants
- Peer Reviewers
- Executive Summary
- Introduction
- Methods
- Results
- Results of Literature Searches
- Key Question 1A. Outcome Measures Used in RPS Studies
- Key Question 1B. Psychometric Properties of Outcome Measures Used in RPS Studies
- Key Question 1C. Psychometric Properties of Other Possible Outcome Measures
- Key Question 2. Effect of RPS on Health-related Quality of Life, Activities of Daily Living, Visual Function, and Other Outcomes
- Key Question 3. RPSs to Arrest the Progression of Retinitis Pigmentosa
- Key Question 4. Adverse Events of RPSs
- Key Question 5A. Off-label use of RPSs
- Key Question 5B. Other Uses of RPSs
- Discussion
- References
- Abbreviations and Acronyms
- Appendix A. Search Strategies
- Appendix B. Excluded Studies
- Appendix C. Evidence Tables
Suggested citation:
Fontanarosa J, Treadwell J, Samson DJ, VanderBeek BL, Schoelles, K. Retinal Prostheses in the Medicare Population. AHRQ Publication No. XXX. Rockville, MD: Agency for Healthcare Research and Quality; 2016.
This report is based on research conducted by the (ECRI Institute-Penn Medicine EPC) under contract to AHRQ, Rockville, MD (Contract No. HHSA-290-2015-00005-I). The findings and conclusions in this document are those of the authors, who are responsible for its contents. The findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.
None of the investigators has any affiliations or financial involvement related to the material presented in this report.
- 1
5600 Fishers Lane, Rockville, Maryland 20857
- Review Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force[ 2013]Review Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task ForceLin JS, O'Connor E, Rossom RC, Perdue LA, Burda BU, Thompson M, Eckstrom E. 2013 Nov
- Review Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force[ 2014]Review Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task ForcePiper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Smith N, Webber E, Perdue LA, Bigler KD, Whitlock EP. 2014 Dec
- Review Screening for Skin Cancer in Adults: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force[ 2016]Review Screening for Skin Cancer in Adults: An Updated Systematic Evidence Review for the U.S. Preventive Services Task ForceWernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Whitlock EP. 2016 Jul
- Review Screening for Chronic Obstructive Pulmonary Disease: A Systematic Evidence Review for the U.S. Preventive Services Task Force[ 2016]Review Screening for Chronic Obstructive Pulmonary Disease: A Systematic Evidence Review for the U.S. Preventive Services Task ForceGuirguis-Blake JM, Senger CA, Webber EM, Mularski R, Whitlock EP. 2016 Apr
- Review Effectiveness of Portable Monitoring Devices for Diagnosing Obstructive Sleep Apnea: Update of a Systematic Review[ 2004]Review Effectiveness of Portable Monitoring Devices for Diagnosing Obstructive Sleep Apnea: Update of a Systematic ReviewLux L, Boehlecke B, Lohr KN. 2004 Sep 1
- Retinal Prostheses in the Medicare PopulationRetinal Prostheses in the Medicare Population
- BioProject Links for BioSample (Select 12056556) (2)BioProject
- Taxonomy Links for Nucleotide (Select 1087902418) (1)Taxonomy
- Staphylococcus sp. HMSC062D04 genomic scaffold Scaffold254, whole genome shotgun...Staphylococcus sp. HMSC062D04 genomic scaffold Scaffold254, whole genome shotgun sequencegi|1087902323|gnl|WGS:LTFP01|Scaffo |gb|KV805924.1|Nucleotide
- Staphylococcus sp. HMSC062D04 genomic scaffold Scaffold152, whole genome shotgun...Staphylococcus sp. HMSC062D04 genomic scaffold Scaffold152, whole genome shotgun sequencegi|1087902369|gnl|WGS:LTFP01|Scaffo |gb|KV805917.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...